🇺🇸 FDA
Pipeline program

QGC001 [(3S,3'S)-4,4'-dithiobis (3-aminobutane-1-sulfonic acid)]

QGC001/1QG2

Phase 1 small_molecule completed

Quick answer

QGC001 [(3S,3'S)-4,4'-dithiobis (3-aminobutane-1-sulfonic acid)] for Essential Hypertension is a Phase 1 program (small_molecule) at Quantum Biopharma with 2 ClinicalTrials.gov record(s).

Program details

Company
Quantum Biopharma
Indication
Essential Hypertension
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials